Cargando…
Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation
BACKGROUND: Chronic heart failure (CHF) is a serious and prevalent condition characterized by impaired cardiac function and inflammation. Standard therapy for CHF has limitations, prompting the exploration of alternative treatments. Recombinant human brain natriuretic peptide (BNP) has emerged as a...
Autores principales: | Li, Feng, Li, Hao, Luo, Rong, Pei, Jia-Bao, Yu, Xue-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507552/ https://www.ncbi.nlm.nih.gov/pubmed/37731575 http://dx.doi.org/10.12998/wjcc.v11.i26.6066 |
Ejemplares similares
-
Analysis of the Effect of Lyophilized Recombinant Human Brain Natriuretic Peptide on Endothelial Function in patients with acute myocardial infarction
por: Wang, Bosong, et al.
Publicado: (2021) -
Association of frailty with in-hospital outcomes in elderly patients with heart failure
por: Kang, Yun-Peng, et al.
Publicado: (2021) -
Recombinant human brain natriuretic peptide ameliorates venous return function in congestive heart failure
por: Luo, Jing‐chao, et al.
Publicado: (2022) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019) -
Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)